Neuralstem Announces the Appointment of Two New Members to the Board of Directors

GERMANTOWN, Md., Sept. 25 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Zhang Zhuo and Cristina Csimma, PharmD, MHP, have been appointed to its Board of Directors, effective September 18, 2017. “I’m very pleased to welcome Mr. Zhang and Dr. Csimma to our Board,” [...]